During checkout, this product may be reported as "Out of Stock" with an Estimated Availability date. The Actual Availability date for this product may be earlier. Send inquiries regarding Actual Availability date, including the catalog number, to discoverysciences@lifetech.com.

CellSensor™ Myc-bla HCT116 Cell Line

Catalog number:  K1467

Related applications:

Cellular Imaging

| Pharma & Biopharma

Back to top


The CellSensor™Myc-bla HCT116 cell line contains a beta-lactamase reporter gene under the control of Myc binding sequences. The construct was transduced into HCT116 cells using a lentiviral system. HCT116 is a colon cancer cell line which expresses a mutated form of beta-catenin. This form of beta-catenin leads to the accumulation of beta-catenin and constitutive activation of downstream genes such as Myc. This cell line is a clonal population isolated by flow cytometry. It has been validated for cell plating density and DMSO tolerance. The signaling pathway has been validated using RNAi against c-Myc and ICG-001, an inhibitor of the wnt-beta-catenin pathway. The expression of the mutant beta-catenin in HCT116 cells results in constitutive activation of beta-lactamase in this CellSensor™line, which can be knocked down by ICG-001 (Figure 1) or Myc RNAi (Figure 2).
For Research Use Only. Not for use in diagnostic procedures.


Assay Entry: Cell-based beta lactamase reporter gene
Cell Line: HCT-116
Cell State: Dividing Cells
Detection Method: Fluorescent
Druggable Target: Signaling Pathway
Product Line: CellSensor™
System Type: CellSensor™
Target Entry: Myc pathway, MYC

Contents & storage

CellSensor® Myc-bla HCT116 cells are shipped on dry ice.
Store in liquid nitrogen immediately upon receipt, or thaw for immediate use.